Kang et al. found that high methylation levels in the promoter region of the SLC6A4 gene were associated with an increased risk of composite cardiovascular events, including recurrent stroke, myocardial infarction, and vascular death, up to 14 years after ischemic stroke [120]. The gene discussed is SLC6A4; the disease is stroke disorder.